Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
Investor excitement about smaller medtechs’ technology is unchecked, but these groups will have to deliver on their promises.
The industry leader’s biggest buy since Covidien gets it into robots, but direct competition with Intuitive is unlikely.
Wright's bone filler sales are growing fast, but Medtronic still rules.
Intuitive Surgical is the winner in terms of sales per employee, despite increasing its headcount 17%.